<?xml version='1.0' encoding='utf-8'?>
<document id="30978991"><sentence text="Potential Pharmacokinetic Drugâ»Drug Interaction Between Harmine, a Cholinesterase Inhibitor, and Memantine, a Non-Competitive N-Methyl-d-Aspartate Receptor Antagonist."><entity charOffset="56-63" id="DDI-PubMed.30978991.s1.e0" text="Harmine" /><entity charOffset="97-106" id="DDI-PubMed.30978991.s1.e1" text="Memantine" /><entity charOffset="126-146" id="DDI-PubMed.30978991.s1.e2" text="N-Methyl-d-Aspartate" /><pair ddi="false" e1="DDI-PubMed.30978991.s1.e0" e2="DDI-PubMed.30978991.s1.e0" /><pair ddi="false" e1="DDI-PubMed.30978991.s1.e0" e2="DDI-PubMed.30978991.s1.e1" /><pair ddi="false" e1="DDI-PubMed.30978991.s1.e0" e2="DDI-PubMed.30978991.s1.e2" /><pair ddi="false" e1="DDI-PubMed.30978991.s1.e1" e2="DDI-PubMed.30978991.s1.e1" /><pair ddi="false" e1="DDI-PubMed.30978991.s1.e1" e2="DDI-PubMed.30978991.s1.e2" /></sentence><sentence text="Harmine (HAR) is a beta-carboline alkaloid widely distributed in nature"><entity charOffset="0-7" id="DDI-PubMed.30978991.s2.e0" text="Harmine" /><entity charOffset="9-12" id="DDI-PubMed.30978991.s2.e1" text="HAR" /><entity charOffset="19-42" id="DDI-PubMed.30978991.s2.e2" text="beta-carboline alkaloid" /><pair ddi="false" e1="DDI-PubMed.30978991.s2.e0" e2="DDI-PubMed.30978991.s2.e0" /><pair ddi="false" e1="DDI-PubMed.30978991.s2.e0" e2="DDI-PubMed.30978991.s2.e1" /><pair ddi="false" e1="DDI-PubMed.30978991.s2.e0" e2="DDI-PubMed.30978991.s2.e2" /><pair ddi="false" e1="DDI-PubMed.30978991.s2.e1" e2="DDI-PubMed.30978991.s2.e1" /><pair ddi="false" e1="DDI-PubMed.30978991.s2.e1" e2="DDI-PubMed.30978991.s2.e2" /></sentence><sentence text=" It exhibits psychopharmacological effects of improving learning and memory" /><sentence text=" However, excessive dose of HAR can cause central tremor toxicity, which may be related to the glutamate system"><entity charOffset="95-104" id="DDI-PubMed.30978991.s4.e0" text="glutamate" /><entity charOffset="28-36" id="DDI-PubMed.30978991.s4.e1" text="HAR" /><pair ddi="false" e1="DDI-PubMed.30978991.s4.e1" e2="DDI-PubMed.30978991.s4.e1" /><pair ddi="false" e1="DDI-PubMed.30978991.s4.e1" e2="DDI-PubMed.30978991.s4.e0" /></sentence><sentence text=" Memantine (MEM) is a non-competitive N-methyl-d-aspartate receptor antagonist"><entity charOffset="1-10" id="DDI-PubMed.30978991.s5.e0" text="Memantine" /><entity charOffset="12-15" id="DDI-PubMed.30978991.s5.e1" text="MEM" /><entity charOffset="38-58" id="DDI-PubMed.30978991.s5.e2" text="N-methyl-d-aspartate" /><pair ddi="false" e1="DDI-PubMed.30978991.s5.e0" e2="DDI-PubMed.30978991.s5.e0" /><pair ddi="false" e1="DDI-PubMed.30978991.s5.e0" e2="DDI-PubMed.30978991.s5.e1" /><pair ddi="false" e1="DDI-PubMed.30978991.s5.e0" e2="DDI-PubMed.30978991.s5.e2" /><pair ddi="false" e1="DDI-PubMed.30978991.s5.e1" e2="DDI-PubMed.30978991.s5.e1" /><pair ddi="false" e1="DDI-PubMed.30978991.s5.e1" e2="DDI-PubMed.30978991.s5.e2" /></sentence><sentence text=" It can be used for the treatment of Alzheimer's disease and also can block the neurotoxicity caused by glutamate"><entity charOffset="104-113" id="DDI-PubMed.30978991.s6.e0" text="glutamate" /></sentence><sentence text=" Therefore, combination of HAR and MEM would be meaningful and the pharmacokinetics investigation of HAR and MEM in combination is necessary"><entity charOffset="27-35" id="DDI-PubMed.30978991.s7.e0" text="HAR" /><entity charOffset="101-109" id="DDI-PubMed.30978991.s7.e1" text="HAR" /><entity charOffset="35-43" id="DDI-PubMed.30978991.s7.e2" text="MEM" /><entity charOffset="109-117" id="DDI-PubMed.30978991.s7.e3" text="MEM" /><pair ddi="false" e1="DDI-PubMed.30978991.s7.e0" e2="DDI-PubMed.30978991.s7.e0" /><pair ddi="false" e1="DDI-PubMed.30978991.s7.e0" e2="DDI-PubMed.30978991.s7.e2" /><pair ddi="false" e1="DDI-PubMed.30978991.s7.e0" e2="DDI-PubMed.30978991.s7.e1" /><pair ddi="false" e1="DDI-PubMed.30978991.s7.e0" e2="DDI-PubMed.30978991.s7.e3" /><pair ddi="false" e1="DDI-PubMed.30978991.s7.e2" e2="DDI-PubMed.30978991.s7.e2" /><pair ddi="false" e1="DDI-PubMed.30978991.s7.e2" e2="DDI-PubMed.30978991.s7.e1" /><pair ddi="false" e1="DDI-PubMed.30978991.s7.e2" e2="DDI-PubMed.30978991.s7.e3" /><pair ddi="false" e1="DDI-PubMed.30978991.s7.e1" e2="DDI-PubMed.30978991.s7.e1" /><pair ddi="false" e1="DDI-PubMed.30978991.s7.e1" e2="DDI-PubMed.30978991.s7.e3" /></sentence><sentence text=" A ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method was established and validated for the simultaneous quantitative determination of MEM, HAR and harmol (HOL), a main metabolite of HAR, in rat plasma after oral administration of HAR and MEM in combination (5"><entity charOffset="182-188" id="DDI-PubMed.30978991.s8.e0" text="harmol" /><entity charOffset="174-179" id="DDI-PubMed.30978991.s8.e1" text="HAR" /><entity charOffset="217-222" id="DDI-PubMed.30978991.s8.e2" text="HAR" /><entity charOffset="265-270" id="DDI-PubMed.30978991.s8.e3" text="HAR" /><entity charOffset="169-174" id="DDI-PubMed.30978991.s8.e4" text="MEM" /><entity charOffset="273-278" id="DDI-PubMed.30978991.s8.e5" text="MEM" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e4" e2="DDI-PubMed.30978991.s8.e4" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e4" e2="DDI-PubMed.30978991.s8.e1" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e4" e2="DDI-PubMed.30978991.s8.e0" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e4" e2="DDI-PubMed.30978991.s8.e2" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e4" e2="DDI-PubMed.30978991.s8.e3" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e4" e2="DDI-PubMed.30978991.s8.e5" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e1" e2="DDI-PubMed.30978991.s8.e1" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e1" e2="DDI-PubMed.30978991.s8.e0" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e1" e2="DDI-PubMed.30978991.s8.e2" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e1" e2="DDI-PubMed.30978991.s8.e3" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e1" e2="DDI-PubMed.30978991.s8.e5" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e0" e2="DDI-PubMed.30978991.s8.e0" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e0" e2="DDI-PubMed.30978991.s8.e2" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e0" e2="DDI-PubMed.30978991.s8.e3" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e0" e2="DDI-PubMed.30978991.s8.e5" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e2" e2="DDI-PubMed.30978991.s8.e2" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e2" e2="DDI-PubMed.30978991.s8.e3" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e2" e2="DDI-PubMed.30978991.s8.e5" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e3" e2="DDI-PubMed.30978991.s8.e3" /><pair ddi="false" e1="DDI-PubMed.30978991.s8.e3" e2="DDI-PubMed.30978991.s8.e5" /></sentence><sentence text="0 mg/kg of MEM combined with 20"><entity charOffset="11-13" id="DDI-PubMed.30978991.s9.e0" text="MEM" /></sentence><sentence text="0, 40" /><sentence text="0, 80" /><sentence text="0 mg/kg of HAR)"><entity charOffset="11-13" id="DDI-PubMed.30978991.s12.e0" text="HAR" /></sentence><sentence text=" The contents of HAR and HOL were determined after oral administration of HAR (20"><entity charOffset="17-19" id="DDI-PubMed.30978991.s13.e0" text="HAR" /><entity charOffset="74-76" id="DDI-PubMed.30978991.s13.e1" text="HAR" /><pair ddi="false" e1="DDI-PubMed.30978991.s13.e0" e2="DDI-PubMed.30978991.s13.e0" /><pair ddi="false" e1="DDI-PubMed.30978991.s13.e0" e2="DDI-PubMed.30978991.s13.e1" /></sentence><sentence text="0, 40" /><sentence text="0 and 80" /><sentence text="0 mg/kg), and the content of MEM was determined after oral administration of MEM (5"><entity charOffset="29-31" id="DDI-PubMed.30978991.s16.e0" text="MEM" /><entity charOffset="77-79" id="DDI-PubMed.30978991.s16.e1" text="MEM" /><pair ddi="false" e1="DDI-PubMed.30978991.s16.e0" e2="DDI-PubMed.30978991.s16.e0" /><pair ddi="false" e1="DDI-PubMed.30978991.s16.e0" e2="DDI-PubMed.30978991.s16.e1" /></sentence><sentence text="0 mg/kg)" /><sentence text=" Blood samples were collected from each rat at 0 (pre-dose), 0" /><sentence text="08, 0" /><sentence text="17, 0" /><sentence text="25, 0" /><sentence text="33, 0" /><sentence text="50, 0" /><sentence text="75, 1" /><sentence text="0, 2" /><sentence text="0, 4" /><sentence text="0, 8" /><sentence text="0, 12" /><sentence text="0 and 24" /><sentence text="0 h after administration" /><sentence text=" The maximum peak concentration (Cmax) of MEM was obviously decreased, and the area under the plasma concentration versus time curve from zero to time t (AUC(0-t)) and mean residence time (MRT) were significantly increased after combination with HAR"><entity charOffset="246-248" id="DDI-PubMed.30978991.s31.e0" text="HAR" /><entity charOffset="42-44" id="DDI-PubMed.30978991.s31.e1" text="MEM" /><pair ddi="false" e1="DDI-PubMed.30978991.s31.e1" e2="DDI-PubMed.30978991.s31.e1" /><pair ddi="false" e1="DDI-PubMed.30978991.s31.e1" e2="DDI-PubMed.30978991.s31.e0" /></sentence><sentence text=" The Cmax and AUC(0-t) of HAR and its metabolite HOL were increased after combination with MEM"><entity charOffset="26-28" id="DDI-PubMed.30978991.s32.e0" text="HAR" /><entity charOffset="91-93" id="DDI-PubMed.30978991.s32.e1" text="MEM" /><pair ddi="false" e1="DDI-PubMed.30978991.s32.e0" e2="DDI-PubMed.30978991.s32.e0" /><pair ddi="false" e1="DDI-PubMed.30978991.s32.e0" e2="DDI-PubMed.30978991.s32.e1" /></sentence><sentence text=" These findings suggested that co-administration of HAR and MEM could extend their residence time in rats, and then might increase the efficacy for treatment of Alzheimer's disease"><entity charOffset="52-54" id="DDI-PubMed.30978991.s33.e0" text="HAR" /><entity charOffset="60-62" id="DDI-PubMed.30978991.s33.e1" text="MEM" /><pair ddi="false" e1="DDI-PubMed.30978991.s33.e0" e2="DDI-PubMed.30978991.s33.e0" /><pair ddi="false" e1="DDI-PubMed.30978991.s33.e0" e2="DDI-PubMed.30978991.s33.e1" /></sentence><sentence text=" Therefore, this study will provide a basis for the rational combined application of HAR and MEM"><entity charOffset="85-87" id="DDI-PubMed.30978991.s34.e0" text="HAR" /><entity charOffset="93-95" id="DDI-PubMed.30978991.s34.e1" text="MEM" /><pair ddi="false" e1="DDI-PubMed.30978991.s34.e0" e2="DDI-PubMed.30978991.s34.e0" /><pair ddi="false" e1="DDI-PubMed.30978991.s34.e0" e2="DDI-PubMed.30978991.s34.e1" /></sentence><sentence text="" /></document>